Literature DB >> 2502831

Modulation of both interleukin 2 receptor expression and interleukin 2 production during experimental murine Trypanosoma cruzi infection.

M Rottenberg1, C Lindqvist, A Koman, E L Segura, A Orn.   

Abstract

A massive activation of T cells takes place during the early stages of a Trypanosoma cruzi infection in mice. We present data indicating that substantial amounts of interleukin 2 (IL-2) are secreted and IL-2 receptors are expressed during the period of increased proliferation (4-7 days post infection). Both concanavalin A-induced proliferation and IL-2 production are markedly decreased later in the acute infection (around 3 weeks post infection). This proliferation cannot be restored by externally added IL-2. Simultaneously, there is a drastic reduction in the number of both high- and low-affinity IL-2 receptors. The reduction is not attributable to the elimination of a particular T-cell population. In vivo administration of recombinant IL-2 failed to improve resistance to T. cruzi parasites as measured by parasitaemia and mortality.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2502831     DOI: 10.1111/j.1365-3083.1989.tb01189.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  7 in total

1.  Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase.

Authors:  C Hölscher; G Köhler; U Müller; H Mossmann; G A Schaub; F Brombacher
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

2.  Interleukin-12 stimulation of lymphoproliferative responses in Trypanosoma cruzi infection.

Authors:  A P Galvão da Silva; I de Almeida Abrahamsohn
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

3.  Gamma interferon modulates CD95 (Fas) and CD95 ligand (Fas-L) expression and nitric oxide-induced apoptosis during the acute phase of Trypanosoma cruzi infection: a possible role in immune response control.

Authors:  G A Martins; L Q Vieira; F Q Cunha; J S Silva
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

4.  Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease.

Authors:  F Kierszenbaum; H M Lopez; M B Sztein
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

5.  Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells.

Authors:  F Cardillo; J C Voltarelli; S G Reed; J S Silva
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

6.  Does interleukin-2 restore lymphocyte responses suppressed by Trypanosoma cruzi?

Authors:  F Kierszenbaum; H Mejia Lopez; M B Sztein
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

7.  Interleukin-2 receptors in experimental Chagas' disease.

Authors:  D R Pakianathan; R E Kuhn
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.